A dab of gel on the breathing tube might spare surgery patients a sore throat — a trial puts it to the test.
NCT ID NCT07040631
First seen Jul 24, 2026 · Last updated Jul 24, 2026
Summary
This trial tests whether applying a hyaluronic acid gel (Endotra Gel) to the breathing tube before general anesthesia can reduce sore throat, hoarseness, and coughing after breast cancer surgery. About 132 adults undergoing breast cancer surgery will be randomly assigned to receive the gel or standard care. Researchers will track symptoms right after surgery and the next day to see if the gel improves comfort and recovery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- a hyaluronic acid-based gel (Endotra Gel) applied to the endotracheal tube cuff before intubation
- What this could lead to
- If it works, this simple gel application could become a routine way to prevent throat discomfort after surgery under general anesthesia.
- What could go wrong
- This is a small, early-stage trial. The gel may not reduce symptoms more than standard care, and individual results may vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
132 people
The number who actually took part.
- Started
-
Aug 2025
- Finished
-
Apr 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
19 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults aged 19 to 80 years * Scheduled to undergo breast cancer surgery under general anesthesia with endotracheal intubation * American Society of Anesthesiologists (ASA) physical status I to III Exclusion Criteria: * Mallampati classification of III or higher * Recent upper respiratory infection or symptoms of upper airway infection * Pre-existing laryngeal disease or chronic respiratory conditions (e.g., asthma, chronic bronchitis) * Current use of systemic steroids * Refusal to provide informed consent * Determined to be unsuitable for study participation by the investigator
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Pusan national university yangsan hospital
Yangsan, Gyeongsangnam-do, 50612, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Retrospective analysis of pyrotinib in the treatment of HER2-Positive advanced breast cancer previously treated with trastuzumab and pertuzumab
- Mind and body: does resilience leave a molecular mark in breast cancer?
- Which pain block works better for breast surgery?
- Can a Triple-Drug combo erase HER2-Positive breast tumors before surgery?
- Bacteria inside tumors may hold the key to breast cancer treatment
- Can a newer drug ease the bone pain of chemotherapy support?